| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| P M Carvey, L R Ptak, D Lin, E S Lo, C M Buhrfiend, G E Drucker, J Z Field. Alterations in striatal neurotrophic activity induced by dopaminergic drugs. Pharmacology, biochemistry, and behavior. vol 46. issue 1. 1994-01-10. PMID:7902982. |
the administration of dopaminergic drugs induces a variety of compensatory responses ostensibly designed to reinstate normal dopamine (da) tone. |
1994-01-10 |
2023-08-12 |
rat |
| I Merchenthale. Induction of enkephalin in tuberoinfundibular dopaminergic neurons during lactation. Endocrinology. vol 133. issue 6. 1994-01-06. PMID:7694844. |
single- and double-labeling immunocytochemistry was used to demonstrate that the tuberoinfundibular dopaminergic (tida) neurons of lactating rats, in contrast to those of male or female rats on any day of the estrous cycle, synthesize enkephalin which is colocalized with dopamine. |
1994-01-06 |
2023-08-12 |
rat |
| S Rosenzweig-Lipson, J Bergma. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys. The Journal of pharmacology and experimental therapeutics. vol 267. issue 2. 1994-01-06. PMID:7902432. |
other dopaminergic drugs, including the d1 partial agonists skf 75670 and r(+)-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-[1h]-3- benzazepine (r-skf 38393), and the indirect dopamine agonists, cocaine, d-amphetamine and 1-(2-[bis(4-fluorophenyl)methoxy]ethyl)-4-(3-phenylpropyl)piperazine (gbr 12909), did not substitute fully for skf 81297 in any monkey studied. |
1994-01-06 |
2023-08-12 |
monkey |
| S R Nash, N Godinot, M G Caro. Cloning and characterization of the opossum kidney cell D1 dopamine receptor: expression of identical D1A and D1B dopamine receptor mRNAs in opossum kidney and brain. Molecular pharmacology. vol 44. issue 5. 1994-01-06. PMID:8246914. |
to identify dopamine receptor subtypes present in renal tissue, as well as to explore the usefulness of opossum kidney cells for the study of d1 dopamine receptors and renal dopaminergic physiology, we have undertaken the cloning and characterization of the dopamine receptor expressed in this cell line. |
1994-01-06 |
2023-08-12 |
human |
| R Dawson, R Felheim, M I Phillip. Dopamine receptor agonists and antagonists both inhibit dopamine secretion in LLC-PK1 cells. European journal of pharmacology. vol 240. issue 2-3. 1994-01-03. PMID:7902285. |
llc-pk1 cells were incubated with l-3,4-dihydroxyphenylalanine (l-dopa) (250 microm) in the presence and absence of dopaminergic drugs known to be selective for dopamine receptor subtypes and total dopamine synthesis and dopamine secretion into the media were measured directly by high performance liquid chromatography (hplc). |
1994-01-03 |
2023-08-12 |
Not clear |
| R Dawson, R Felheim, M I Phillip. Dopamine receptor agonists and antagonists both inhibit dopamine secretion in LLC-PK1 cells. European journal of pharmacology. vol 240. issue 2-3. 1994-01-03. PMID:7902285. |
the mechanism of action for these dopaminergic drugs appeared to involve the inhibition of dopamine secretion from llc-pk1 cells by direct competition for outward transport by an organic cation transporter. |
1994-01-03 |
2023-08-12 |
Not clear |
| A J Bouckoms, W H Sweet, C Poletti, P Lavori, D Carr, W Matson, P Gamache, N Aroni. Monoamines in the brain cerebrospinal fluid of facial pain patients. Anesthesia progress. vol 39. issue 6. 1993-12-30. PMID:7504420. |
these results indicate that (1) the electrochemical detection method provides a unique way of accurately measuring nanogram concentrations of multiple monoamines in a little as 0.25 ml of csf; (2) trigeminal cistern and posterior fossa brain csf monoamine metabolites reflect a different profile of dopaminergic and serotonergic functioning in these facial pain patients from that previously reported with lumbar csf measurements of other patients; and (3) trigeminal sensory ganglion or brain dopamine and serotonin systems may be concomitantly dysfunctional in intractable facial pain. |
1993-12-30 |
2023-08-12 |
Not clear |
| W J Florijn, A J Holtmaat, H de Lang, H Spierenburg, W H Gispen, D H Verstee. Peptide-induced grooming behavior and caudate nucleus dopamine release. Brain research. vol 625. issue 1. 1993-12-29. PMID:8242396. |
these data are in support of the proposed involvement of brain dopamine systems in grooming behavior of the rat but at the same time suggest that the effect of acth/msh-like peptides on dopaminergic transmission in the caudate nucleus is proximal to the final neural pathway involved in acth-induced grooming behavior. |
1993-12-29 |
2023-08-12 |
rat |
| P M Grasby, K J Friston, C J Bench, P J Cowen, C D Frith, P F Liddle, R S Frackowiak, R J Dola. The effect of the dopamine agonist, apomorphine, on regional cerebral blood flow in normal volunteers. Psychological medicine. vol 23. issue 3. 1993-12-22. PMID:7901864. |
apomorphine, a non-selective dopamine agonist, has been used as a pharmacological probe for investigating central dopaminergic neurotransmission in psychiatric illness. |
1993-12-22 |
2023-08-12 |
human |
| J L Montastruc, O Rascol, J M Senar. Current status of dopamine agonists in Parkinson's disease management. Drugs. vol 46. issue 3. 1993-12-21. PMID:7693430. |
apomorphine is a non-ergot derivative dopamine agonist, which is used subcutaneously for the treatment of severe 'off' refractory periods, in combination with other dopaminergic drugs without changing the patient's routine drug regimen. |
1993-12-21 |
2023-08-12 |
Not clear |
| B Säfsten, G Flemströ. Dopamine and vasoactive intestinal peptide stimulate cyclic adenosine-3',5'-monophosphate formation in isolated rat villus and crypt duodenocytes. Acta physiologica Scandinavica. vol 149. issue 1. 1993-12-15. PMID:7901964. |
previously, we have shown that dopaminergic compounds stimulate the duodenal bicarbonate secretion in situ, in the anaesthetized rat, through an action on peripheral dopamine d1 receptors. |
1993-12-15 |
2023-08-12 |
rat |
| A Antonini, K L Leender. Dopamine D2 receptors in normal human brain: effect of age measured by positron emission tomography (PET) and [11C]-raclopride. Annals of the New York Academy of Sciences. vol 695. 1993-12-10. PMID:8239318. |
these results suggest that dopamine d2 receptor binding sites (mainly post-synaptically located) decrease as a consequence of normal aging in parallel with the decline of the pre-synaptic nigrostriatal dopaminergic system. |
1993-12-10 |
2023-08-12 |
human |
| D A Wink, I Hanbauer, M C Krishna, W DeGraff, J Gamson, J B Mitchel. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proceedings of the National Academy of Sciences of the United States of America. vol 90. issue 21. 1993-12-09. PMID:8234317. |
similarly, primary cultures of rat mesencephalic dopaminergic cells exposed either to hydrogen peroxide or to hypoxanthine/xanthine oxidase resulted in the degradation of the dopamine uptake and release mechanism. |
1993-12-09 |
2023-08-12 |
rat |
| J Weil-Fugazza, B Onteniente, G Audet, E Philipp. Dopamine as trace amine in the dorsal root ganglia. Neurochemical research. vol 18. issue 9. 1993-12-07. PMID:8232724. |
the present work indicates that there is a dopaminergic innervation of the blood vessels in the rat drg but that dopamine may also be, as in the chick, a transmitter of primary afferent fibers. |
1993-12-07 |
2023-08-12 |
rat |
| M Chritin, C Feuerstein, M Savast. Time-course of changes in striatal levels of DA uptake sites, DA D2 receptor and preproenkephalin mRNAs after nigrostriatal dopaminergic denervation in the rat. Brain research. Molecular brain research. vol 19. issue 4. 1993-12-01. PMID:8231735. |
changes in striatal dopamine uptake sites, d2 receptor and preproenkephalin (ppe) mrna levels provoked by unilateral 6-hydroxydopamine-induced lesion of the nigrostriatal dopaminergic (da) pathway were studied by quantitative autoradiography and in situ hybridization (ish) in rats sacrificed at different post-lesion delays. |
1993-12-01 |
2023-08-12 |
rat |
| Y Nishikawa, H Ikegami, H Jikihara, K Koike, N Masumoto, K Kasahara, K Tasaka, K Hirota, A Miyake, O Tanizaw. Effects of thyrotropin-releasing hormone and phorbol ester on dopamine release from dispersed rat tuberoinfundibular dopaminergic neurons. Peptides. vol 14. issue 4. 1993-12-01. PMID:8234033. |
effects of thyrotropin-releasing hormone and phorbol ester on dopamine release from dispersed rat tuberoinfundibular dopaminergic neurons. |
1993-12-01 |
2023-08-12 |
rat |
| Y Nishikawa, H Ikegami, H Jikihara, K Koike, N Masumoto, K Kasahara, K Tasaka, K Hirota, A Miyake, O Tanizaw. Effects of thyrotropin-releasing hormone and phorbol ester on dopamine release from dispersed rat tuberoinfundibular dopaminergic neurons. Peptides. vol 14. issue 4. 1993-12-01. PMID:8234033. |
we have investigated the intracellular mechanisms underlying thyrotropin-releasing hormone (trh)-mediated [3h]dopamine ([3h]da) release from dispersed rat tuberoinfundibular dopaminergic (tida) neurons. |
1993-12-01 |
2023-08-12 |
rat |
| M L Myers, G H Li, A Yaghi, D McCormac. Human internal thoracic artery reactivity to dopaminergic agents. Circulation. vol 88. issue 5 Pt 2. 1993-11-29. PMID:7900930. |
the purpose of this study was to characterize the vascular reactivity of human ita to dopaminergic agents used in patients undergoing coronary bypass surgery (cbs): dopamine, dobutamine, and dopexamine. |
1993-11-29 |
2023-08-12 |
human |
| K Xu, L Näveri, K U Frerichs, J M Hallenbeck, G Feuerstein, J N Davis, A L Siré. Extracellular catecholamine levels in rat hippocampus after a selective alpha-2 adrenoceptor antagonist or a selective dopamine uptake inhibitor: evidence for dopamine release from local dopaminergic nerve terminals. The Journal of pharmacology and experimental therapeutics. vol 267. issue 1. 1993-11-29. PMID:7901393. |
extracellular catecholamine levels in rat hippocampus after a selective alpha-2 adrenoceptor antagonist or a selective dopamine uptake inhibitor: evidence for dopamine release from local dopaminergic nerve terminals. |
1993-11-29 |
2023-08-12 |
rat |
| E Ronken, A H Mulder, A N Schoffelmee. Interacting presynaptic kappa-opioid and GABAA receptors modulate dopamine release from rat striatal synaptosomes. Journal of neurochemistry. vol 61. issue 5. 1993-11-29. PMID:8228982. |
in conclusion, striatal dopamine release is under regulatory control of multiple excitatory and inhibitory neurotransmitter by activation of colocalized presynaptic receptors for excitatory amino acids, acetylcholine, dopamine, dynorphins, and gaba within the dopaminergic nerve terminals. |
1993-11-29 |
2023-08-12 |
human |